Using mouse models of obesity coupled with xenografts of human adipose, ablation of p21Cip1 positive cells in adipose tissue, through either pharmacological or genetic means, alleviated the development of metabolic dysfunction (Wang et al., 2022). The gene discussed is CDKN1A; the disease is obesity disorder.